Saturday, July 11, 2026

Drug profile · INN

depreotide

depreotide (NEOSPECT) is an FDA-listed pharmaceutical active ingredient.

EMA: withdrawn Various (V09) V09IA05
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — depreotide
Class
Various (V09)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

depreotide (NEOSPECT) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN depreotide
Brand NEOSPECT
Therapeutic class Various (V09)
ATC code V09IA05

Approval history

Authority Status Date
EMA withdrawn

Pipeline programs

  1. SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM Phase 3 · Ars Pharmaceuticals Irl · Amyotrophic Lateral Sclerosis

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is depreotide?

depreotide (NEOSPECT) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for depreotide?

NEOSPECT is a marketed brand name for depreotide. Check FDA Drugs@FDA for the current US label holder and prescribing information.